The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in ...

Mesothelioma is an aggressive tumor with a poor prognosis. Histological diagnosis of mesothelioma using limited tissue samples can be challenging. Carbonic anhydrase IX (CAIX) is a transmembrane ...

Post-conference recap highlights direct anti-tumor effects in epithelial and non-epithelioid mesothelioma models, >90% tumor growth inhibition in vivo when TT-4 was combined with anti-PD-1, and ...

(a) Hematoxylin and eosin (H&E) stain (100×) on a needle biopsy specimen showing clusters of epithelioid tumor cells in a fibrotic stroma. (b) Corresponding area to (a) with positive nuclear and ...

Stage 1 mesothelioma is localized. The cancer is confined to one side of the chest lining or one area of the abdomen and has not spread to lymph nodes or distant organs. At this stage, treatment may ...

The global multicenter Phase I trial of ISM6331 that is enrolling patients in China and the United States has advanced with the dosing of the first patient in this study for the treatment of ...

With four FDA-approved oncology indications and trials exploring new uses, tumor treating fields are emerging as a promising therapeutic option for certain patients with cancer. While using ...